China Pharma receives non-compliance letter from NYSE American

Jun. 22, 2022 5:33 PM ETChina Pharma Holdings, Inc. (CPHI)By: Mary Christine Joy, SA News Editor

Stock Exchange Sign

FrankvandenBergh/E+ via Getty Images

  • China Pharma Holdings (NYSE:CPHI) said it received a letter from NYSE American on non-compliance with continued listing standards.
  • CPHI is required to submit a plan of compliance by Jul. 15 to maintain its listing on the exchange.
  • The plan should address how it intends to regain compliance by Dec. 15, 2023.
  • The specialty pharmaceutical company's shares will continue to trade under the ticker symbol CPHI, but will have an added designation of .BC. The designation indicates it is not in compliance with the NYSE American's listing standards.
  • Shares were trading +3.50% post-market.
  • Source: Press Release
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.